Company intelligence / Profile preview

Salus

Ownership: Private
Employees: ~600
Development stage: Commercial

Overview

Salus is a leading commercialization and distribution partner for healthcare and biotech companies seeking to expand in Central and Eastern Europe. It provides complete distribution, promotion, active sales services, logistics support, and value-added solutions necessary for medicinal products and medical devices to reach the market. In 2024 it achieved €650 million turnover with about 600 employees.

Industry: Non-Academic Healthcare

Partnerships

Includes partnerships with international pharmaceutical companies and manufacturers of innovative/orphan medicinal products for regional commercialization/distribution in Central/Eastern Europe

Beyond the preview

Go deeper on Salus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salus.

Explore the full profile